BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29189508)

  • 1. Steroid-induced Hypertension During Induction Chemotherapy for Acute Lymphoblastic Leukemia in US Children's Hospitals.
    Bakk I; Koch T; Stanek J; O'Brien SH; Reed S
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):27-30. PubMed ID: 29189508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid-induced Bradycardia During Induction Chemotherapy in Children and Young Adults Diagnosed With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.
    Duffy C; Hall L; Godown J; Koyama T; Borinstein SC
    J Pediatr Hematol Oncol; 2019 Oct; 41(7):537-541. PubMed ID: 30994505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of an 11-year cohort of 8733 pediatric patients hospitalized at United States free-standing children's hospitals with de novo acute lymphoblastic leukemia from health care administrative data.
    Fisher BT; Harris T; Torp K; Seif AE; Shah A; Huang YS; Bailey LC; Kersun LS; Reilly AF; Rheingold SR; Walker D; Li Y; Aplenc R
    Med Care; 2014 Jan; 52(1):e1-6. PubMed ID: 22410405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of Posterior Reversible Encephalopathy Syndrome in Children With Acute Lymphoblastic Leukemia After Induction Chemotherapy.
    Tang JH; Tian JM; Sheng M; Hu SY; Li Y; Zhang LY; Gu Q; Wang Q
    J Child Neurol; 2016 Mar; 31(3):279-84. PubMed ID: 26060305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid-induced ocular hypertensive response in pediatric patients with acute lymphoblastic leukemia.
    Sawada M; Takachi T; Watanabe K; Tsuchiya Y; Nishimura K; Hotta Y; Sato M
    Jpn J Ophthalmol; 2023 Jul; 67(4):396-401. PubMed ID: 37310574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Mineral Metabolism During Chemotherapy in Childhood Acute Lymphoblastic Leukemia: Unexpected Vitamin D Deficiency From Induction Corticosteroids in Acute Lymphoblastic Leukemia.
    Gahr K; Sommers N; Bostrom B
    J Pediatr Hematol Oncol; 2021 Aug; 43(6):240-241. PubMed ID: 33290292
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute respiratory infections in children and adolescents with acute lymphoblastic leukemia.
    Hakim H; Dallas R; Zhou Y; Pei D; Cheng C; Flynn PM; Pui CH; Jeha S
    Cancer; 2016 Mar; 122(5):798-805. PubMed ID: 26700662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114).
    Rheingold SR; Tasian SK; Whitlock JA; Teachey DT; Borowitz MJ; Liu X; Minard CG; Fox E; Weigel BJ; Blaney SM
    Br J Haematol; 2017 May; 177(3):467-474. PubMed ID: 28295182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predisposing factors of posterior reversible encephalopathy syndrome in acute childhood leukemia.
    Kim SJ; Im SA; Lee JW; Chung NG; Cho B; Kim HK; Lee IG
    Pediatr Neurol; 2012 Dec; 47(6):436-42. PubMed ID: 23127265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High blood pressure and hypertension in children with newly diagnosed acute leukemia and lymphoma.
    Louis CU; Butani L
    Pediatr Nephrol; 2008 Apr; 23(4):603-9. PubMed ID: 18224346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity in pediatric patients with acute lymphoblastic leukemia increases the risk of adverse events during pre-maintenance chemotherapy.
    Meenan CK; Kelly JA; Wang L; Ritchey AK; Maurer SH
    Pediatr Blood Cancer; 2019 Feb; 66(2):e27515. PubMed ID: 30362242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication-induced diabetes during induction treatment for ALL, an early marker for future metabolic risk?
    Yeshayahu Y; Koltin D; Hamilton J; Nathan PC; Urbach S
    Pediatr Diabetes; 2015 Mar; 16(2):104-8. PubMed ID: 24673941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Hospital Length of Stay on Readmissions for Children With Newly Diagnosed Acute Lymphoblastic Leukemia.
    Wedekind MF; Dennis R; Sturm M; Koch T; Stanek J; O'Brien SH
    J Pediatr Hematol Oncol; 2016 Jul; 38(5):329-33. PubMed ID: 26989914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Day 22 of induction therapy is important for minimal residual disease assessment by flow cytometry in childhood acute lymphoblastic leukemia.
    Xu XJ; Tang YM; Shen HQ; Song H; Yang SL; Shi SW; Xu WQ
    Leuk Res; 2012 Aug; 36(8):1022-7. PubMed ID: 22483330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiety, pain, and nausea during the treatment of standard-risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children's Oncology Group.
    Dupuis LL; Lu X; Mitchell HR; Sung L; Devidas M; Mattano LA; Carroll WL; Winick N; Hunger SP; Maloney KW; Kadan-Lottick NS
    Cancer; 2016 Apr; 122(7):1116-25. PubMed ID: 26773735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious complications in children with acute lymphoblastic leukemia treated with the Taiwan Pediatric Oncology Group protocol: A 16-year tertiary single-institution experience.
    Li MJ; Chang HH; Yang YL; Lu MY; Shao PL; Fu CM; Chou AK; Liu YL; Lin KH; Huang LM; Lin DT; Jou ST
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28371256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating childhood acute lymphoblastic leukemia in a developing country 1998-2003: the experience of a single children's hospital in China.
    Gao YJ; Lu FJ; Wang HS
    J Pediatr Hematol Oncol; 2006 Dec; 28(12):798-802. PubMed ID: 17164648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of Influenza-Related Hospitalizations and Attributable Mortality in Pediatric Acute Lymphoblastic Leukemia.
    Lee GE; Fisher BT; Xiao R; Coffin SE; Feemster K; Seif AE; Bagatell R; Li Y; Huang YS; Aplenc R
    J Pediatric Infect Dis Soc; 2015 Dec; 4(4):290-6. PubMed ID: 26582867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posterior Reversible Encephalopathy Syndrome: Risk Factors and Impact on the Outcome in Children With Acute Lymphoblastic Leukemia Treated With Nordic Protocols.
    Banerjee JS; Heyman M; Palomäki M; Lähteenmäki P; Arola M; Riikonen PV; Möttönen MI; Lönnqvist T; Taskinen MH; Harila-Saari AH
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):e13-e18. PubMed ID: 29200159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight change during childhood acute lymphoblastic leukemia induction therapy predicts obesity: a report from the Children's Oncology Group.
    Withycombe JS; Smith LM; Meza JL; Merkle C; Faulkner MS; Ritter L; Seibel NL; Moore K
    Pediatr Blood Cancer; 2015 Mar; 62(3):434-9. PubMed ID: 25407299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.